Uncategorized
Phakic IOLs have reduced but still important role in European ophthalmology
Brought to the market in the late 1980s, phakic IOLs promised to be the solution for patients with high refractive error who were not eligible for corneal laser surgery. The initial enthusiasm cooled down in the following years due to long-term sight-threatening complications that induced companies to repeatedly modify some of the existing IOL designs and eventually withdraw several models from the market.Although the use of phakic IOLs did not expand as much as was expected at first, this technology still has a well-established role, according to Antonio Marinho, MD, (Read more...)